Interleukin 10 and TNFα synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia

Neurobiology of Disease

Volumn 27, Issue 1, 2007, Pages 90-98

  Iribarren, Pablo ^a,c   Chen, Keqiang ^a   Gong, Wanghua ^b   Cho, Edward H ^b   Lockett, Stephen ^b   Uranchimeg, Badarch ^b   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Chemotaxis; Cytokines; Inflammation; Neuroimmunology; Protein Kinases

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; FORMYLPEPTIDE RECEPTOR 2; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); FORMYL PEPTIDE RECEPTOR 2, MOUSE; FORMYLPEPTIDE RECEPTOR; HLA ANTIGEN CLASS 2; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; CONTROLLED STUDY; ENDOCYTOSIS; INFLAMMATION; MICROGLIA; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY;

AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE; CHEMOTAXIS; DRUG SYNERGISM; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROIMMUNOMODULATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; RECEPTORS, FORMYL PEPTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250359477     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2007.04.010     Document Type: Article

References (51)

1. Apelt J., and Schliebs R. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 894 (2001) 21-30
2. Ard M.D., et al. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J. Neurosci. Res. 43 (1996) 190-202
3. Bard F., et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6 (2000) 916-919
4. Chen K., et al. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 281 (2006) 3651-3659
5. Cua D.J., et al. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166 (2001) 602-608
6. Cui Y., et al. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J. Leukoc. Biol. 72 (2002) 628-635
7. Cui Y., et al. Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha. Neurobiol. Dis. 10 (2002) 366-377
8. Cui Y.H., et al. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J. Immunol. 168 (2002) 434-442
9. Deckert M., et al. Endogenous Interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in listeria monocytogenes meningoencephalitis. Infect. Immun. 69 (2001) 4561-4571
10. DeWitt D.A., et al. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149 (1998) 329-340
11. El Khoury J., et al. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 382 (1996) 716-719
12. Flaris N.A., et al. Characterization of microglia and macrophages in the central nervous system of rats: definition of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia 7 (1993) 34-40
13. Frautschy S.A., et al. Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol. Aging 17 (1996) 311-321
14. Gonzalez-Scarano F., and Martin-Garcia J. The neuropathogenesis of AIDS. Nat. Rev., Immunol. 5 (2005) 69-81
15. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
16. Hirsch E.C., et al. The role of glial reaction and inflammation in Parkinson's disease. Ann. N. Y. Acad. Sci. 991 (2003) 214-228
17. Hull M., et al. Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs. Curr. Med. Chem. 9 (2002) 83-88
18. Iribarren P., et al. CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid and beta; 1-42 peptide by up-regulating the expression of the G-protein-coupled receptor mFPR2. FASEB J. (2005) (05-4578fje)
19. Iribarren P., et al. IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia. J. Immunol. 175 (2005) 6100-6106
20. Iribarren P., et al. Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. Immunol. Res. 31 (2005) 165-176
21. Koistinaho M., and Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40 (2002) 175-183
22. Kuhn R., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
23. Le Y., et al. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 163 (1999) 6777-6784
24. Le Y., et al. Amyloid {beta}42 activates a G-protein-coupled chemoattractant receptor, FPR-Like-1. J. Neurosci. 21 (2001) 123RC
25. Le Y., et al. Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev. 12 (2001) 91-105
26. Le Y., et al. Formyl-peptide receptors revisited. Trends Immunol. 23 (2002) 541-548
27. Le Y., et al. TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J. Immunol. 173 (2004) 962-968
28. Lombardo J.A., et al. Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J. Neurosci. 23 (2003) 10879-10883
29. Minagar A., et al. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J. Neurol. Sci. 202 (2002) 13-23
30. Mosmann T.R. Properties and functions of interleukin-10. Adv. Immunol. 56 (1994) 1-26
31. Pahan K., et al. Inhibitors of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages. J. Biol. Chem. 273 (1998) 12219-12226
32. Paresce D.M., et al. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17 (1996) 553-565
33. Pocock J.M., et al. Activated microglia in Alzheimer's disease and stroke. Ernst Schering Res. Found. (2002) 105-132
34. Rogers J., and Lue L.F. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem. Int. 39 (2001) 333-340
35. Schenk D., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999) 173-177
36. Shanley T.P., et al. The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling. J. Immunol. 166 (2001) 966-972
37. Sorensen T.L., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103 (1999) 807-815
38. Sozzani S., et al. Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187 (1998) 439-444
39. Spera P., et al. IL-10 reduces rat brain injury following focal stroke. Neurosci. Lett. 251 (1998) 189-192
40. Stalder M., et al. 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol. Aging 22 (2001) 427-434
41. Strle K., et al. IL-10 promotes survival of microglia without activating Akt. J. Neuroimmunol. 122 (2002) 9-19
42. Tiffany H.L., et al. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276 (2001) 23645-23652
43. van der Poll T., et al. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155 (1995) 5397-5401
44. Wang J.M., et al. Interleukin-10 modulates the chemokine receptor expression on monocytes. J. Cell. Biochem., Suppl. 18B (1994) 320
45. Wilcock D.M., et al. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. J. Neurosci. 23 (2003) 3745-3751
46. Winston B.W., and Riches D.W. Activation of p42mapk/erk2 following engagement of tumor necrosis factor receptor CD120a (p55) in mouse macrophages. J. Immunol. 155 (1995) 1525-1533
47. Wu Z., et al. Leptomeningeal cells activate microglia and astrocytes to induce IL-10 production by releasing pro-inflammatory cytokines during systemic inflammation. J. Neuroimmunol. 167 (2005) 90-98
48. Wyss-Coray T., et al. TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7 (2001) 612-618
49. Yan S.D., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
50. Yazawa H., et al. Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15 (2001) 2454-2462
51. Ying G., et al. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172 (2004) 7078-7085